6-(2,6-dichlorophenyl)-2-(4-(2-diethylaminoethoxy)phenylamino)-8-methyl-8H-pyrido(2,3-d)pyrimidin-7-one,
PD 166285,
PD-166285,
212391-63-4,
PD 166285,
PD 166285 2HCl,
PD 166285 dihydrochloride,
6-(2,6-dichlorophenyl)-2-[[4-[2-(diethylamino)ethoxy]phenyl]amino]-8-methylpyrido[2,3-d]pyrimidin-7(8H)-onedihydrochloride,
PD166285/PD-166285,
CHEMBL3545196,
SCHEMBL15106017,
CTK8E7972,
DTXSID80432749,
EX-A1369,
AKOS024457798,
BCP9001063,
BCP0726000019,
RT-014958,
FT-0673536,
J-013945,
6-(2,6-Dichlorophenyl)-2-[[4-[2-(diethylamino)ethoxy]phenyl]amino]-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one dihydrochloride,
Heparin-Cantithrombin III,
D04CQG,
PD-166285,
NADLBPWBFGTESN-UHFFFAOYSA-N,
CID9916391,
CID 9916391,
PD166285,
PD-0166285,
A13868,
C109647,
6-(2,6-dichlorophenyl)-2-(4-(2-diethylaminoethoxy)phenylamino)-8-methyl-8h-pyrido(2,3-d)pyrimidin-7-one,